General Information of the Compound
| Compound ID |
CP0147996
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CHEBI:8093
Show/Hide
|
||||||||||||||||||
| Synonyms |
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
Ah-Chew
Ak-dilate
Ak-nefrin
Alcon Efrin
Alconefrin Nasal Drops 12
Alconefrin Nasal Drops 25
Alconefrin Nasal Drops 50
Alconefrin Nasal Spray 25
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-(9CI)
Cyclomydril
Dilatair
Dionephrine
Doktors
Duration
Fenilefrina
Fenilefrina [INN-Spanish]
I-Phrine
Isophrim
Isophrin
Isopto Frin
L-(3-Hydroxyphenyl)-N-methylethanolamine
L-1-(m-Hydroxyphenyl)-2-methylaminoethanol
L-Phenylephedrine
L-Phenylephrine
L-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
L-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
M-Methylaminoethanolphenol
M-Oxedrine
M-Sympathol
M-Sympatol
M-Synephrine
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
Metasympatol
Metasynephrine
Metsatonum
Mezaton
Minims Phenylephrine
Mydfrin
Mydfrin (TN)
Neo-Synephrine
Neo-Synephrine Nasal Drops
Neo-Synephrine Nasal Jelly
Neo-Synephrine Nasal Spray
Neofrin
Neosynephrine
Nostril
Nostril Spray Pump
Nostril Spray Pump Mild
Ocu-Phrin Sterile Eye Drops
Ocugestrin
Phenoptic
Phenylephrine
Phenylephrine (INN)
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine [INN:BAN]
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin Liquifilm
R(-)-Phenylephrine
Relief Eye Drops for Red Eyes
Spersaphrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
Visadron
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H13NO2
|
||||||||||||||||||
| Molecular Weight |
167.208
|
||||||||||||||||||
| Canonical SMILES |
CNC[C@H](O)c1cccc(O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SONNWYBIRXJNDC-VIFPVBQESA-N
|
||||||||||||||||||
| CAS |
1416-03-1
59-42-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02060, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT00644, Alpha-1B adrenergic receptor
Protein ID: PT01650, Alpha-2A adrenergic receptor
Protein ID: PT01598, Alpha-2C adrenergic receptor
Protein ID: PT06796, POU domain, class 2, transcription factor 1
Clinical Information about the Compound